فارماسی تایم 💊
💊کانال اختصاصی دانشجویان و فارغ التحصیلان داروسازی💊 پل ارتباطی جهت ارسال مطلب و #تبلیغات: 👇 @pharmacytimeee لینک پیام ناشناس به کانال فارماسی تایم: https://t.me/HarfBeManBOT?start=HBM12415848
Show more📈 Analytical overview of Telegram channel فارماسی تایم 💊
Channel فارماسی تایم 💊 (@pharmacytimee) in the Farsi language segment is an active participant. Currently, the community unites 16 049 subscribers, ranking 1 504 in the Medicine category and 20 477 in the Iran region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 16 049 subscribers.
According to the latest data from 16 June, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 200 over the last 30 days and by 29 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 23.80%. Within the first 24 hours after publication, content typically collects 18.78% reactions from the total number of subscribers.
- Post reach: On average, each post receives 3 819 views. Within the first day, a publication typically gains 3 013 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 136.
- Thematic interests: Content is focused on key topics such as دانشکده, علم, داروسازی, داروخانه, داروساز.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“💊کانال اختصاصی دانشجویان و فارغ التحصیلان داروسازی💊
پل ارتباطی جهت ارسال مطلب و #تبلیغات: 👇
@pharmacytimeee
لینک پیام ناشناس به کانال فارماسی تایم:
https://t.me/HarfBeManBOT?start=HBM12415848”
Thanks to the high frequency of updates (latest data received on 17 June, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Available now! Telegram Research 2025 — the year's key insights 
